Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.

Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.

Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.

Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.

Abstract: Example methods of quantifying known and unknown risks of an adverse drug event in an individual based on various factors are disclosed. In some embodiments, factors include known drug-drug interactions and unknown phenotypes of cytochromes. Quantification may be based on severity of the adverse drug event/and or probability of occurrence in some embodiments. Example methods of displaying the quantified risk are also disclosed. In one embodiment, the risk of individuals is aggregated to display the risk of a population.

Abstract: Service parts inventory planning and management are provided for one or more entities in a supply chain (12), preferably within the context of an electronic marketplace (14). Status data reflecting substantially current service parts inventory levels at stocking locations within the supply chain (12) is accessed, these inventory levels indicating service parts excesses or needs at one or more stocking locations. A substantially current service parts inventory plan is generated according to the status data, a service parts demand forecast, and a supply chain model, the inventory plan including target stocking levels for service parts at stocking locations. According to the inventory plan, one or more services are initiated to attempt to resolve service parts excesses or needs at stocking locations through interaction with one or more other entities.

Abstract: Service parts inventory planning and management are provided for one or more entities in a supply chain (12), preferably within the context of an electronic marketplace (14). Status data reflecting substantially current service parts inventory levels at stocking locations within the supply chain (12) is accessed, these inventory levels indicating service parts excesses or needs at one or more stocking locations. A substantially current service parts inventory plan is generated according to the status data, a service parts demand forecast, and a supply chain model, the inventory plan including target stocking levels for service parts at stocking locations. According to the inventory plan, one or more services are initiated to attempt to resolve service parts excesses or needs at stocking locations through interaction with one or more other entities.

Abstract: Service parts inventory planning and management are provided for one or more entities in a supply chain (12), preferably within the context of an electronic marketplace (14). Status data reflecting substantially current service parts inventory levels at stocking locations within the supply chain (12) is accessed, these inventory levels indicating service parts excesses or needs at one or more stocking locations. A substantially current service parts inventory plan is generated according to the status data, a service parts demand forecast, and a supply chain model, the inventory plan including target stocking levels for service parts at stocking locations.